CRI Homepage > Resources & Publications > News & Reports > E-Newsletter > Cancer ImmuNews (2:4) December 2009
|
Volume 2, Issue 4 |
December 2009 |
|
IN THIS ISSUE Vaccine Breakthrough:
New Treatment for HPV Infection
Be Someone's Angel:
Donate to CRI Today
Conquering Melanoma:
Screens to Predict Patient Survival
QUICK LINKS CRI Homepage
Donate to CRI
Contact Us
Subscribe to Cancer ImmuNews
GIVE WISELY
CRI consistently earns top marks from leading charity watchdogs.
SHARE CRI's STORY
Help the cause by forwarding this email to three of your friends. Be sure to tell them why you support our work. Don't forget to do all your online holiday shopping with GoodShop.com to benefit CRI
STAY IN THE KNOW
Subscribe to our other free channels to get CRI updates & cancer news:
   
Thank you for your support.
|
CRI researchers from The Netherlands have published results from a study of a vaccine that could lead to new treatments for people who have already been infected with the human papilomavirus and who are at risk of developing genitourinary and other types of cancer caused by HPV infection.
 |
Although the chances of surviving advanced melanoma aren’t very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now CRI researchers have discovered that it may be possible to identify which patients are more likely to survive by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation.
More Progress in the Clinic >>
|
|
|
| Forward this message to a friend | Phone: (212) 688-7515 or Toll-free (800) 99-CANCER |